Trial
NCT06611930
CK-0045 Proof-of-concept Study in Participants With Overweight / Obesity and Type 2 Diabetes
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Cytoki Pharma
Collaborators
Profil Institut für Stoffwechselforschung GmbH; CRS Clinical Research Services Mannheim GmbH
Condition
Type 2 Diabetes Mellitus (T2DM)
Intervention
CK-0045
Why stopped
The study was terminated after the recruitment had been completed due to a decision to discontinue development of CK-0045
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-20